NCT06422351Phase 2Suspended

Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency

Study sponsor: Rocket Pharmaceuticals Inc. · RCKT

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-01Estimated
Enrollment · participants10Estimated
Source updated2026-04-16Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Primary completion date changed

Before: Nov 2026. After: Jan 2029.

Recruitment status changed

Before: Not yet recruiting. After: Suspended.

Check registry source